Ding X, Zhang WJ, You R, Zou X, et al. Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study. J Clin Oncol 2023 Feb 3:JCO2201450. doi: 10.1200/JCO.22.01450.
PMID: 36735896